Prior to his current position, Dr. Powers was the Lead Medical Officer for Antimicrobial Drug Development and Resistance Initiatives at the US Food and Drug Administration. Dr. Powers was co-chair for the US Federal Inter-Agency Task Force on Antimicrobial Resistance. He also was a co-author on the Guidance for Patient Reported Outcomes, and Chair of the ISPOR Clinical Outcomes Assessment task force. Prior to joining the FDA, Dr. Powers was assistant professor in the Division of Infectious Diseases at the University of Maryland School of Medicine where he still is on the faculty. Dr.